Wednesday, May 21, 2014 9:02:25 AM
In a former life, I worked filing a lot of applications with government agencies (mainly FDA and USDA). From personal experience, I can tell you that our government is not very efficient, and is mired in red tape.
The fact that they received back information from the FDA with specifics about Sucanon meeting the criteria of a "drug" in the US, is huge. The normal process usually entails having to meet all of the filing requirements, and only at the time of awaiting "final approval", do they come out with "Oh, wait. This should have been treated as a drug, not as a neutraceutical", and the company or individual having to start all over at square one again (process and cost).
Having clear definition of "drug", ROTH can now proceed down the correct path towards compliance and acceptance, while getting real time, real world results from the OTC sales in Latin and South America.
Perhaps it's a blessing in disguise, so long as we don't lose the forest because a tree or 2 gets in the way.
Best.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM